Skip to main content
. Author manuscript; available in PMC: 2011 Dec 1.
Published in final edited form as: J Card Fail. 2010 Dec;16(12):931–937. doi: 10.1016/j.cardfail.2010.07.253

Table 1.

Baseline Characteristics of the Study Population.

NI (n=585) PI (n=124) II (n=50) SD (n=94) p-value adjusted p-value

Demographics

Age, y 66.1 ± 12.1 (68) 67.9 ± 10.6 (70) 68.3 ± 9.2 (69) 65.0±14.4 (66) 0.34# >0.999
Male, n 426 (72.8%) 89 (71.8%) 36 (72.0%) 66 (70.2%) 0.96 >0.999
HF duration, mos 61± 64(41) 69 ± 67(55) 76 ± 73 (59) 72 ± 81(50) 0.45 0.999

ECG Findings

QRS duration, ms 171 ± 30 (169) 168 ± 30 (160) 172 ± 34 (170) 170 ± 32 (170) 0.67 0.998
RBBB, n 59 (10.3%) 9 (7.4%) 6 (12.0%) 17 (18.9%) 0.05 0.986

Comorbidities

Diabetes, n 204 (34.9%) 53 (43.1%) 27 (54.0%) 35 (37.6%) 0.03 >0.999
GFR, mL/min 62 ± 24 (60) 55 ± 20 (54) 52 ± 26 (48) 59 ± 28 (59) 0.001# 0.992
Known atrial fibrillation, n 274 (46.8%) 71 (57.7%) 29 (58.0%) 44 (48.4%) 0.09 >0.999
Ischemic HF, n 317 (54.3%) 83 (66.9%) 32 (64.0%) 56 (60.2%) 0.04 0.995
NYHA class 4, n 12 (2.1%) 10 (8.1%) 20 (40.0%) 3 (3.2%) <0.001 -

Echocardiography

LVEF, % 22.3 ± 6.9 (22) 20.6 ± 6.4 (21) 20.3 ± 7.4 (22) 23.1±10.3 (22) 0.07# 0.999
LVEDD, cm 6.27 ± 0.88 (6.2) 6.26 ± 0.95 (6.2) 6.23 ± 1.00 (6.2) 6.12±0.77 (6.0) 0.65 0.895
LVESD, cm 5.34 ± 0.98 (5.3) 5.32 ± 0.98 (5.4) 5.43 ± 1.16 (5.6) 4.98±0.99 (4.9) 0.09 0.454

Pharmacologic Therapy

β-blocker, n 488 (83.4%) 88 (71.0%) 27 (54.0%) 72 (77.4%) <0.001 0.996
ACE-I/ARB, n 500 (85.5%) 104 (83.9%) 37 (74.0%) 76 (81.7%) 0.17 >0.999
Aldosterone antagonist, n 157 (26.8%) 22 (17.7%) 14 (28.0%) 18 (19.4%) 0.10 >0.999

RBBB: right bundle-branch block. GFR: glomerular filtration rate. LVESD: left ventricular end-systolic diameter. LVEDD: left ventricular end-diastolic diameter. ACE-I: angiotensin-converting enzyme-inhibitor. ARB: angiotensin receptor blocker. Numbers in parentheses are median values except if followed by %. P-values denoted with # are based on Kruskal-Wallis or Fisher's Exact tests. P-values reflect 4-way comparison. Adjusted p-values reflect adjustment for propensity scores.